Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

Article Abstract:

A study is conducted to document the short-term efficacy of a selective serotonin reuptake inhibitor (citalopram) and interpersonal psychotherapy (IPT) in reducing depressive symptoms in patients with coronary artery disease (CAD) and major depression. Results show no evidence of added value of IPT over clinical management, indicating that citalopram or sertraline plus clinical management should be considered as a first-step treatment for patients with CAD and major depression.

Author: Dorian, Paul, Baker, Brian, Frasure-Smith, Nancy, Lesperance, Francois, Koszycki, Diana, Laliberte, Marc-Andre, van Zyl, Louis T., Swenson, John Robert, Ghatavi, Kayhan, Abramson, Beth L., Guertin, Marie-Claude
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
United States, Drug therapy, Serotonin uptake inhibitors, Selective serotonin reuptake inhibitors, Clinical report, Interpersonal psychotherapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Depression -- a cardiac risk factor in search of a treatment

Article Abstract:

Treating heart attack patients for their depression may not necessarily improve their prognosis, according to a study published in 2003. This was surprising because other studies showed that heart attack patients with depression have lower survival rates compared to non-depressed patients. An overall improvement in the care of heart attack patients in general may have minimized the impact of treatment for depression.

Author: Frasure-Smith, Nancy, Lesperance, Francois
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003
Editorial

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) randomized trial

Article Abstract:

Treating heart attack patients for their depression may be effective but it will not prolong their survival, according to a study of 2,481 patients. Some received usual care and others received cognitive behavior therapy and medication if necessary. This study was done because research has shown that heart attack patients who are depressed have a worse prognosis than other heart attack patients.

Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003
Evaluation, Cognitive therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Depression, Mental, Depression (Mood disorder), Psychological aspects, Care and treatment, Patient outcomes, Heart attack
Similar abstracts:
  • Abstracts: Effect of Mechanical Ventilation on Inflammatory Mediators in Patients With Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
  • Abstracts: Effect of estrogen plus progestin on global cognitive function in postmentopausal women: a randomized controlled trial
  • Abstracts: Effect of estrogen plus progestin on global cognitive function in postmentopausal women: a randomized controlled trial. part 2
  • Abstracts: Low-fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized dietary modification trial
  • Abstracts: Researchers probe depression in children. Scientists use neuroimaging, genetic studies to probe biology of Tourette syndrome
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.